PeopleBio

PeopleBio Net Debt / EBITDA

The Net Debt to EBITDA of PeopleBio (304840.KQ) as of Nov 1, 2026 is 0.57. In the previous year, Net Debt to EBITDA was 0.29 — a change of 96.83% (higher).

Net Debt / EBITDA

0.57

YoY

96.83%

Last updated:

Net Debt to EBITDA of PeopleBio is 2024 0.57 . Net Debt to EBITDA of PeopleBio was 2023 0.29 . It decreases by 96.83% higher compared to the previous year.

The PeopleBio Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2017
0.90 KRW
Jan 1, 2018
1.59 KRW
Jan 1, 2019
0.73 KRW
Jan 1, 2020
2.10 KRW
Jan 1, 2021
5.61 KRW
Jan 1, 2022
1.88 KRW
Jan 1, 2023
0.29 KRW
Jan 1, 2024
0.57 KRW
The PeopleBio Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
0.57+96.83%
0.29-84.49%
1.88-66.49%
5.61+167.67%
2.10+187.87%
0.73-54.12%
1.59+76.92%
0.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

PeopleBio Stock analysis

What does PeopleBio do? PeopleBio, Inc. generates revenue through the sale of oligomerized beta-amyloid (OAβ) test systems and multimer detection system (MDS) products. The company's MDS is a sandwich assay technology using capturing antibodies and epitope-overlapping detection antibodies to detect oligomers or multimers in protein-misfolding diseases. Products are sold domestically and internationally to customers in the biotechnology and healthcare sectors. The firm's primary focus is on diagnostic solutions for protein-misfolding conditions. PeopleBio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PeopleBio stock

Net Debt to EBITDA of PeopleBio is 0.57 in 2024.

Net Debt to EBITDA of PeopleBio changed from 0.29 to 0.57, representing a 96.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA PeopleBio since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's PeopleBio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — PeopleBio

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — PeopleBio